Organ donation and utilitarianism: Medical ethics is more important than medical effectiveness;Organdonation och utilitarism: Läkaretiken väger tyngre än medicinsk effektivitet

Lakartidningen

Volumn 101, Issue 3, 2004, Pages 229-

  Frostegård, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MEDICAL ETHICS; MORALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PHILOSOPHY; SHORT SURVEY; SURGICAL PATIENT;

ETHICAL THEORY; HUMANS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0442309161     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Statens beredning för utvärdering av medicinsk metodik. Måttligt förhöjt blodtryck. Stockholm: SBU; 1994. SBU-rapport 121 (uppdaterad 1998).
2. Moser M. Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 1998;279:1813-6.
3. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30.
4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
5. Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, et al; ALLHAT Collaborative Research Group. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Ann Intern Med 2002;137(5 Part 1):313-20.
6. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283:1967-75.